Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 Post author:Sam Post published:January 31, 2018 Post category:BioPharma Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace You Might Also Like Veloxis Pharma Announces Financial Results For The First Three Months Of 2017 May 15, 2017 6 Biotechs Facing Key FDA Decisions in March February 26, 2017 9 Massachusetts Biotechs Facing Major FDA Decisions This Year March 2, 2017